GLP-1: studies show it can affect the spread of stigma

• In an article for Nature Health, researchers analyzed 410,198 Reddit posts from 2026 and found that GLP-1 had a negative effect, with the spread of stigmatizing stereotypes accelerated by the drug.
• Forbes notes that while the publication is correct to point out the potential for misinformation, it is also important to keep in mind that the internet is not a reliable source for establishing the causes of real-world events.
• Vox argues that GLP-1 use may be linked to stigma, but the findings in Nature do not support the conclusion that the drug is responsible for “spreading stigma” in the way that the publication claims.

Forbes and Vox say their research into the class of GLP-1 drugs (including Ozempic, Mounjaro, Wegovy and Zepbound) found that the studies discussed may not provide enough evidence, and that the conclusions are based on assumptions. Forbes argues that in similar articles, which are based on online reports, it is possible to draw conclusions about what people believe, but it is not possible to determine what caused the stigma. Vox, meanwhile, says that the study’s findings may be consistent with a link between GLP-1 and stigma, but that it cannot be ruled out that other factors are responsible.

Forbes also notes that the study in Nature Health, published in 2026, concluded that GLP-1 had a negative effect on the internet. The company’s AI for analyzing 410,198 Reddit posts posted between 2019 and early 2025 found that 67,008 commenters, who identified as having either used or taken the drug, said that the drug’s effects were most often negative and that 44% reported the least favorable experiences among 2.7 million comments.

Forbes adds that the publication found the most common negative categories were: nausea (37%), weight loss (17%), vomiting (16%), appetite suppression (15%) and diarrhea (13%), as well as other categories. The average of negative experiences was 3.8% among commenters, while the most common was “stomach discomfort” (6.9%), as well as symptoms that were described as temporary (for example, nausea, vomiting, diarrhea, and stomach pain).

Forbes also points out that a separate block of data showed that on Reddit, only 3.1% of commenters mentioned stigma, while the publication also notes that it is possible to interpret the findings as showing that stigma may have been caused by other factors. It says that the drug’s negative effects may have been discussed in a way that could have contributed to stigma, but that it is not necessarily the case that GLP-1 is the direct cause.

Vox focuses on the social spread of GLP-1 stigma. The material says that in the U.S., people may be more likely to stigmatize GLP-1 users, and that Vox argues that the study’s findings may not show that GLP-1 itself causes stigma. Vox also notes that it is possible to interpret the findings differently, and that the study’s conclusions may not be fully supported by the data.

Vox also says it is possible that, based on the study, stigma could be linked to GLP-1. It adds that the study’s findings suggest that 81% of people who mention GLP-1 are likely to be influenced by social factors, and that the drug may not be the only cause. Vox also argues that it is not clear whether the study’s findings show that stigma is caused by GLP-1 itself or by other factors.

Forbes also notes that the study’s conclusions may not be fully supported by the data, and that Vox argues that stigma may be linked to GLP-1 use through social context, which can be influenced by many factors.

Tags: AI/Well-being/Research